Public DataSMD Announcements
SMD NewsSMD Release 2.06
|
Recent PublicationsRegulation of interferon response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment. van Baarsen LG, et al. (2010) Arthritis Res Ther 12(1):R11 IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients. Rajski M, et al. (2010) BMC Med 8(1):1 Molecular signatures of quiescent, mobilized and leukemia-initiating hematopoietic stem cells. Forsberg EC, et al. (2010) PLoS One 5(1):e8785 Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi. Thompson LJ, et al. (2009) Proc Natl Acad Sci U S A 106(52):22433-22438 Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. Hendrickson DG, et al. (2009) PLoS Biol 7(11):e1000238 Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling. Beck AH, et al. (2009) Oncogene (): Industrial fuel ethanol yeasts contain adaptive copy number changes in genes involved in vitamin B1 and B6 biosynthesis. Stambuk BU, et al. (2009) Genome Res 19(12):2271-8 A thiolase of Mycobacterium tuberculosis is required for virulence and production of androstenedione and androstadienedione from cholesterol. Nesbitt NM, et al. (2010) Infect Immun 78(1):275-82 Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer. Buess M, et al. (2009) Neoplasia 11(10):987-1002 The transcriptional regulator Rv0485 modulates the expression of a pe and ppe gene pair and is required for Mycobacterium tuberculosis virulence. Goldstone RM, et al. (2009) Infect Immun 77(10):4654-67 Combination of host susceptibility and Mycobacterium tuberculosis virulence define gene expression profile in the host. Beisiegel M, et al. (2009) Eur J Immunol 39(12):3369-3384 Phthiocerol dimycocerosate transport is required for resisting interferon-gamma-independent immunity. Murry JP, et al. (2009) J Infect Dis 200(5):774-82 | Site InfoSMD Access: Access to non-public data is limited to registered Stanford researchers and their collaborators. Please see SMD Registration for more specific information. If you have further questions regarding access, please e-mail the Stanford Microarray Database curators at array@genome.stanford.edu. Proprietary Data: Please note that some data in the database are proprietary and subject to legal restriction on their use, re-use and distribution. This includes but is not limited to Affymetrix and Agilent oligonucleotide sequences and patented sequences. It is the responsibility of the person viewing or downloading such data to ensure that such use does not infringe on the intellectual property rights of others. Project Funding: The National Human Genome Research Institute at the US National Institutes of Health, and the School of Medicine, Stanford University fund the Microarray Database. The database is a joint project in the Departments of Biochemistry and Genetics at the School of Medicine, Stanford University. Database Copyright © 2001-2008 The Board of Trustees of Leland Stanford Junior University. Permission to use the information contained in this database was given by the researchers/institutes who contributed or published the information. Users of the database are solely responsible for compliance with any copyright restrictions, including those applying to the author abstracts. Documents from this server are provided "AS-IS" without any warranty, expressed or implied. |